FindMyKOL
Clinical trialNCT06513949RecruitingPhase 2Interventional

Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients

SponsorImplicit BioscienceEnrollment56Acute Lung InjuryAcute Lung Injury/Acute Respiratory Distress Syndrome (ARDS)Acute Respiratory Distress SyndromeAdult Respiratory Distress Syndrome
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Hospitalized patients with ARDS will be randomized to intravenous treatment with a monoclonal antibody against CD14, called IC14, or placebo. They will be followed for 28 days. The primary outcome is the day 4 oxygenation index assessed as a continuous measure.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Harborview Medical Center

    Seattle, Washington, United States

    Linzee Mabrey, MD
    Recruiting
  • University of Washington

    Seattle, Washington, United States

    Eric Morrell, MD, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Atibuclimab
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Jun 2026
Primary completion
1 Mar 2029
Completion
1 Jun 2029
Last update posted
29 Jul 2026
Registered enrollment
56
Registry id
NCT06513949

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.